oddish
Well-Known Member
Hi.
Yesterday we introduced Tweed’s 10:1 Cannabis Oils to our customers after receiving our oils sales license from Health Canada. Although we’ll be selling this new line of products at noon today, I’m writing to you now to discuss something else, the decision in Allard et al. v Canada, or simply “Allard.”
As I’m sure many of you know, the Federal Court ruled yesterday that certain aspects of the MMPR regulations, the regulations that govern Tweed and all Licensed Producers, do not adequately give patients sufficient access to the medicine we produce. The court has given the federal government six months to address the shortcomings of the program in its current form.
Today I want to assure you that Tweed isn’t going anywhere. Regardless of the regulatory changes, we are optimistic that any changes to the MMPR system will improve your ability to get the medication you rely on, in a way that meets your needs.
Even though the details won’t come for many months, I wanted to take the chance to reassure you, our valued customer, that Tweed will still be here to provide a truly diverse product line and compassionate service to top it off. As the industry evolves we will work hard to continue to provide you with the products and services you've come to expect from our team. You have many producers to choose from and we never take for granted that you continue to choose Tweed as your trusted supplier.
The road ahead excites us and we hope you share the same sense of optimism.
Here’s to Future Growth (Still).
Mark Zekulin
President, Tweed
Yesterday we introduced Tweed’s 10:1 Cannabis Oils to our customers after receiving our oils sales license from Health Canada. Although we’ll be selling this new line of products at noon today, I’m writing to you now to discuss something else, the decision in Allard et al. v Canada, or simply “Allard.”
As I’m sure many of you know, the Federal Court ruled yesterday that certain aspects of the MMPR regulations, the regulations that govern Tweed and all Licensed Producers, do not adequately give patients sufficient access to the medicine we produce. The court has given the federal government six months to address the shortcomings of the program in its current form.
Today I want to assure you that Tweed isn’t going anywhere. Regardless of the regulatory changes, we are optimistic that any changes to the MMPR system will improve your ability to get the medication you rely on, in a way that meets your needs.
Even though the details won’t come for many months, I wanted to take the chance to reassure you, our valued customer, that Tweed will still be here to provide a truly diverse product line and compassionate service to top it off. As the industry evolves we will work hard to continue to provide you with the products and services you've come to expect from our team. You have many producers to choose from and we never take for granted that you continue to choose Tweed as your trusted supplier.
The road ahead excites us and we hope you share the same sense of optimism.
Here’s to Future Growth (Still).
Mark Zekulin
President, Tweed
no charges,,,,,,and allow lps to just sell it to anyone....d's...cc's or themselves
